900000000000526001: referentieset voor associaties betreffende vervangende concepten (metadata)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Insulin isophane biphasic human 15/85 100units/ml injection 5ml vial	Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 20/80 100units/ml injection 3ml cartridge	Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 20/80 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 25/75 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 25/75 100units/ml injection 5ml vial	Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 30/70 100units/ml injection 10ml vial	Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug)
Insulin isophane biphasic human 30/70 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug)
Insulin isophane biphasic human 40/60 100units/ml injection 3ml cartridge	Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 40/60 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 10ml vial	Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 3ml cartridge	Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 3ml pre-filled disposable injection device	Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic human 50/50 100units/ml injection 5ml vial	Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane biphasic porcine 30/70 100units/ml injection 10ml vial	Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane bovine 100u/mL injection solution 1.5mL cartridge	Bovine isophane insulin 100 unit/mL suspension for injection
Insulin isophane porcine 100u/mL injection solution 1.5mL cartridge	Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane porcine 100u/mL injection solution 10mL vial	Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin isophane porcine 100units/ml injection 10ml vial	Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)
Insulin lispro biphasic (recombinant human insulin analogue) human 25/75 100units/ml injection 3ml cartridge	Product containing precisely insulin lispro 25 unit/1 milliliter and insulin lispro protamine 75 unit/1 milliliter conventional release solution for injection (clinical drug)
Insulin soluble porcine 100u/mL injection solution 1.5mL cartridge	Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug)
Insulin zinc suspension (amorphous) adverse reaction	Adverse reaction to zinc insulin
Insulin zinc suspension (crystalline) adverse reaction	Adverse reaction to zinc insulin
Insulin zinc suspension (crystalline) allergy	Allergy to zinc insulin
Insulin zinc suspension adverse reaction	Adverse reaction to zinc insulin
Intact parathyrin	Parathyroid hormone
Integrated musculoskeletal release	Osteopathic combined treatment method (procedure)
Intentional X-ray contrast media overdose	Intentional X-ray diagnostic contrast media overdose
Intentional X-ray contrast media poisoning	Intentional X-ray diagnostic contrast media overdose
Intentional antabuse overdose	Intentional disulfiram overdose (disorder)
Intentional antabuse poisoning	Intentional disulfiram poisoning (disorder)
Intentional chlorprothixene overdose	Intentional chlorprothixene overdose (disorder)
Intentional pesticide product overdose	Intentional pesticide product poisoning
Intentional zuclopenthixol overdose	Intentional chlorprothixene overdose (disorder)
Interdigital pilonidal sinus	Barber's pilonidal sinus
Interferon alfa-2b 10million iu powder and solvent for injection solution vial	Interferon alfa-2b only product in parenteral dose form
Interferon alfa-2b 10million iu powder for injection solution vial	Interferon alfa-2b only product in parenteral dose form
Interferon alfa-2b 10million iu/mL injection solution 2.5mL vial	Product containing precisely interferon alfa-2b 10 million unit/1 milliliter conventional release solution for injection (clinical drug)
Interferon alfa-2b 18 million iu/vial solution	Interferon alfa-2b only product
Interferon alfa-2b 18million/iu solution	Interferon alfa-2b only product
Interferon alfa-2b 18mu/vial	Interferon alfa-2b only product
Interferon alfa-2b 25 million iu/vial solution	Interferon alfa-2b only product
Interferon alfa-2b 3 million iu/vial solution	Interferon alfa-2b only product
Interferon alfa-2b 30000000iu solution	Interferon alfa-2b only product
Interferon alfa-2b 3million iu powder and solvent for injection solution vial	Interferon alfa-2b only product in parenteral dose form
Interferon alfa-2b 3million iu powder for injection solution vial	Interferon alfa-2b only product in parenteral dose form
Interferon alfa-2b 5 million iu/vial solution	Interferon alfa-2b only product
Interferon alfa-2b 5million iu powder and solvent for injection solution vial	Interferon alfa-2b only product in parenteral dose form
Interferon alfa-2b 5million iu powder for injection solution vial	Interferon alfa-2b only product in parenteral dose form
Interferon alfa-2b 60million/iu solution	Interferon alfa-2b only product
Interferon alfa-n3 human leu 5000000unt/mL injection solution 1mL vial	Product containing precisely interferon alfa-n3 5 million unit/1 milliliter conventional release solution for injection (clinical drug)
Interferon beta-1a 12million iu/mL injection solution 0.5mL prefilled syringe	Interferon beta-1a 30 microgram/mL solution for injection
Interferon beta-1a 24million iu/mL injection solution 0.5mL prefilled syringe	Interferon beta-1a 24 million unit/mL solution for injection
Interferon beta-1a 30mcg/vial injection	Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug)
Interferon beta-1a 30mcg/vial injection solution	Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug)
Interferon beta-1a 6million iu powder and solvent for injection solution vial	Interferon beta-1a only product in parenteral dose form
Interferon beta-1a 6million iu powder for injection solution vial	Interferon beta-1a only product in parenteral dose form
Interferon beta-1b 100mcg injection solution	Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
Interferon beta-1b 8million iu powder and solvent for injection solution vial	Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
Interferon beta-1b 8million iu powder for injection solution vial	Product containing only interferon beta-1b in parenteral dose form (medicinal product form)
Interim report	Interim report (record artifact)
Intermediate factor VIII fraction 250iu powder and solvent for injection solution vial	Coagulation factor VIII only product
Intermediate factor VIII fraction 500iu powder and solvent for injection solution vial	Coagulation factor VIII only product
Intermediate lobe of right lung	Structure of middle lobe of right lung (body structure)
Angiography of internal carotid arteries, bilateral	Angiography of cervicocerebral arteries
Intermediate metabolizer due to cytochrome p450 CYP2C19 variant	CYP2C19 intermediate metabolizer
Intermediate metabolizer due to cytochrome p450 CYP2D6 variant	Cytochrome P450 family 2 subfamily D member 6 intermediate metabolizer (finding)
Intermittent positive pressure ventilation	Positive pressure ventilation
Internal fixation of mandible with arch bars	External fixation of mandible with arch bars (procedure)
Internal fixation of maxilla NEC	Fixation of maxilla - internal
Internal granuloma of pulp	Internal resorption of tooth
Internal haemorrhoids - other	Internal hemorrhoids
Internal hemorrhoids - other	Internal hemorrhoids
Internal injury NOS	Injury of body cavity structure
Internal injury NOS	Injury of body cavity structure
Internal oblique flap	Internal oblique muscle flap
Internal resorption of crown of tooth	Internal resorption of tooth
Internal unsealed radiotherapy NOS	Radionuclide therapy
Internal unsealed radiotherapy NOS	Radionuclide therapy
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IA1	IA1
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IA2	IA2
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IB1	IB1
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IB2	IB2
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIA1	IIA1
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIA2	IIA2
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIB	American Joint Committee on Cancer stage IIB (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIIA	American Joint Committee on Cancer stage IIIA (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IIIB	American Joint Committee on Cancer stage IIIB (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IVA	American Joint Committee on Cancer stage IVA (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage IVB	IVB
International Federation of Gynecology and Obstetrics cervical cancer stage 0	Carcinoma in situ of uterine cervix
International Federation of Gynecology and Obstetrics cervical cancer stage I	I
International Federation of Gynecology and Obstetrics cervical cancer stage II	American Joint Committee on Cancer stage II (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer stage III	American Joint Committee on Cancer stage III (qualifier value)
International Federation of Gynecology and Obstetrics cervical cancer stage IV	IV
International Federation of Gynecology and Obstetrics cervical cancer stage Ia	IA
International Federation of Gynecology and Obstetrics cervical cancer stage Ib	IB
International Federation of Gynecology and Obstetrics cervical cancer stage Ib occ	IB
International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IIIA	American Joint Committee on Cancer stage IIIA (qualifier value)
International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IVA	American Joint Committee on Cancer stage IVA (qualifier value)
International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IVB	IVB
International Federation of Gynecology and Obstetrics endometrial cancer stage I	I

Start Previous Page 65 of 205 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
9093651000146111	referentieset voor associaties betreffende vervangende concepten	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)
9093661000146114	referentieset voor associaties betreffende vervangende concepten (metadata)	nl	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Netherlands NRC maintained module (core metadata concept)